⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy

Official Title:

Study ID: NCT02603159

Study Description

Brief Summary: Definitive chemoradiotherapy with cisplatin with cisplatin plus 5-fluorouracil is the standard in Western countries in esophagus cancer.But in China because of its toxic reaction, most of patients stop the halfway.Because low toxicity, Capecitabine is widely used in the chemotherapy of esophageal cancer. The purpose of this experiment was to study the different cycle on capecitabine with chemotherapy for esophageal cancer chemoradiation effect.We are prepared to within 2 years study recruited 200 patients with esophageal cancer.The primary endpoint is overall survival and the secondary endpoints include progression-free survival, response rate,pathologic complete response rate and adverse events.

Detailed Description: We recruited the patients who were pathologically confirmed with esophageal squamous cell carcinoma from the Oct 2014. The the patients was divided into two groups. Group 1: Capecitabine + chemoradiation, radiation at the end of the stop using capecitabine. Group 2: Capecitabine + chemoradiation, at the end of the radiotherapy with capecitabine consolidating treatment for 5 weeks.

Eligibility

Minimum Age: 45 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China

Contact Details

Name: Shegan Gao, Doctor

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: STUDY_CHAIR

Name: Tanyou Shan, Master

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: STUDY_DIRECTOR

Name: Xiaoshan Feng, Doctor

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: STUDY_DIRECTOR

Name: Jiachun Sun, Doctor

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: PRINCIPAL_INVESTIGATOR

Name: Xinshuai Wang, Doctor

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: PRINCIPAL_INVESTIGATOR

Name: Guoqiang Kong, Master

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: PRINCIPAL_INVESTIGATOR

Name: Xiaozhi Yuan, Master

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: PRINCIPAL_INVESTIGATOR

Name: Ruinuo Jia, Master

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: PRINCIPAL_INVESTIGATOR

Name: Dan Zhuo, Master

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: PRINCIPAL_INVESTIGATOR

Name: Jing Ren, Master

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: PRINCIPAL_INVESTIGATOR

Name: Ruina Yang, Master

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: PRINCIPAL_INVESTIGATOR

Name: Yali Zhang, Master

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: PRINCIPAL_INVESTIGATOR

Name: Yongxuan Liu, Master

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: PRINCIPAL_INVESTIGATOR

Name: Wei Wang, Master

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: PRINCIPAL_INVESTIGATOR

Name: Dan Wang, Master

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: PRINCIPAL_INVESTIGATOR

Name: Weijiao Yin, Master

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: PRINCIPAL_INVESTIGATOR

Name: Shiyuan Song, Master

Affiliation: The First Affiliated Hospital of Henan University of Science and Technology

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: